Interestingly, PlGF is also predicted to activate pathways involved in nitric oxide (NO) production, a key vasodilator with a role in the development of HPS, specifically the pathways identified as ‘eNOS signaling’ and ‘nitric oxide signaling in the cardiovascular system’. Here, NOS3 is linked to Hermansky-Pudlak syndrome.